ITCR Program: Funding Opportunities to Support Informatics Needs Across the Cancer Research Continuum

July 22, 2019 - July 25, 2019
Exhibit Booth #8, Intelligent Systems for Molecular Biology (ISMB) and European Conference on Computational Biology 2019 Conference, Basel, Switzerland

Visit the National Cancer Institute (NCI) Informatics Technology for Cancer Research (ITCR) Program Exhibit Booth #8 to meet ITCR investigators and program staff!

Dr. Juli Klemm will present on informatics funding opportunities with the ITCR Program at the following times (CEST):

  • Monday, July 22, 11:30 a.m. - 12:30 p.m. 
  • Tuesday, July 23, 11:30 a.m. - 12:30 p.m. and 3:00 p.m. - 4:00 p.m.
  • Thursday, July 25, 9:30 a.m. - 10:30 a.m. and 12:30 p.m. - 2:00 p.m.

The annual international conference on Intelligent Systems for Molecular Biology (ISMB) is the flagship meeting of the International Society for Computational Biology (ISCB). ISMB/ECCB brings together scientists from computer science, molecular biology, mathematics, statistics and related fields. Its principal focus is on the development and application of advanced computational methods for biological problems. View the conference program now. 

Juli Klemm, Ph.D.

Dr. Juli Klemm serves as the National Cancer Institute (NCI) Center for Biomedical Informatics and Information Technology (CBIIT) acting Cancer Informatics Branch chief and the NCI Informatics Technology for Cancer Research (ITCR) Program director. Since joining NCI in 2007, her activities have focused largely on programs promoting open science, including the Cancer Genomics Cloud Pilots (now Cloud Resources) and the Center’s open source initiatives. Dr. Klemm received her bachelor’s degree in biology from the University of Utah and her doctorate in biology from the Massachusetts Institute of Technology, where she performed structure-function studies of protein-DNA interactions through x-ray crystallography. She was subsequently a Jane Coffins Childs Postdoctoral Fellow at Stanford University, studying protein export from the nucleus during T-cell signaling. Prior to joining NCI, Dr. Klemm worked at Incyte Corporation, where she was responsible for the management of several genomic information products, and 3rd Millennium, where she served as the Head of Scientific Consulting.

Was this page useful?